Tatsuo Kohriyama Selected Research

Tatsuo Kohriyama Research Topics

Disease

9	Stroke (Strokes) 01/2022 - 03/2002
4	Parkinson Disease (Parkinson's Disease) 01/2017 - 03/2002
3	Ischemic Stroke 09/2015 - 03/2002
3	Multiple Sclerosis 03/2011 - 08/2003
3	Hypoxia (Hypoxemia) 03/2008 - 11/2006
2	Infarction (Infarctions) 09/2015 - 03/2002
2	Ischemia 11/2006 - 11/2003
2	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 04/2004 - 04/2003
1	Aspiration Pneumonia 01/2022
1	Atherosclerotic Plaque (Atheroma) 01/2021
1	Periodontal Pocket (Periodontal Pockets) 01/2021
1	Periodontitis 01/2021
1	Hypertensive Intracranial Hemorrhage 01/2021
1	Myasthenia Gravis 05/2020
1	Atrial Fibrillation 10/2019
1	Dysgeusia (Parageusia) 05/2019
1	Guillain-Barre Syndrome 01/2017
1	Atherosclerosis 09/2015
1	Transient Ischemic Attack 07/2014
1	Hyperlipidemias (Hyperlipidemia) 02/2014
1	Miller Fisher Syndrome (Fisher Syndrome) 12/2012
1	Alexander Disease (Alexander's Disease) 06/2009
1	Leukocytosis (Pleocytosis) 04/2009
1	Dyskinesias (Dyskinesia) 09/2008
1	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 08/2008
1	Motor Neuron Disease (Primary Lateral Sclerosis) 08/2008
1	Opticospinal Multiple Sclerosis 06/2008
1	Disease Progression 06/2008
1	Headache (Headaches) 03/2008
1	Seizures (Absence Seizure) 03/2008
1	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 12/2006
1	Thymoma (Thymic Carcinoma) 12/2006
1	Hypertrophy 04/2004
1	Brain Ischemia (Cerebral Ischemia) 11/2003
1	Human Influenza (Influenza) 08/2003
1	Cardiotoxicity 08/2003
1	Polyneuropathies (Polyneuropathy) 04/2003
1	Parkinsonian Disorders (Parkinsonism) 03/2002

Drug/Important Bio-Agent (IBA)

4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2015 - 12/2005
4	Proteins (Proteins, Gene)FDA Link 04/2009 - 04/2004
3	UbiquitinIBA 08/2008 - 11/2003
2	Carrier Proteins (Binding Protein)IBA 01/2021 - 08/2006
2	Methylprednisolone FDA LinkGeneric 05/2020 - 03/2008
2	Therapeutic UsesIBA 01/2017 - 03/2002
2	Pravastatin (Pravachol)FDA LinkGeneric 09/2015 - 02/2014
2	AntibodiesIBA 12/2012 - 12/2006
2	Mixed Function Oxygenases (Monooxygenases)IBA 03/2008 - 02/2007
1	AlbuminsIBA 01/2022
1	Dexamethasone Isonicotinate (HE 111)IBA 01/2022
1	LipidsIBA 01/2022
1	CollagenIBA 01/2021
1	Antihypertensive Agents (Antihypertensives)IBA 10/2019
1	fasudil (AT 877)IBA 10/2019
1	SodiumIBA 10/2019
1	ozagrelIBA 10/2019
1	Ticlopidine (Ticlid)FDA LinkGeneric 07/2014
1	Clopidogrel (Plavix)FDA Link 07/2014
1	CholesterolIBA 02/2014
1	Glial Fibrillary Acidic ProteinIBA 06/2009
1	Immunoglobulin G (IgG)IBA 04/2009
1	Levodopa (L Dopa)FDA LinkGeneric 09/2008
1	Interferon-betaIBA 06/2008
1	Neutralizing AntibodiesIBA 06/2008
1	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 03/2008
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 03/2008
1	Prednisolone (Predate)FDA LinkGeneric 03/2008
1	Ligases (Synthetase)IBA 02/2007
1	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 12/2006
1	Small Interfering RNA (siRNA)IBA 11/2006
1	rhoA GTP-Binding ProteinIBA 11/2006
1	Monomeric GTP-Binding ProteinsIBA 11/2006
1	rho-Associated KinasesIBA 11/2006
1	alpha-SynucleinIBA 08/2006
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 11/2003
1	Proteasome Endopeptidase Complex (Proteasome)IBA 11/2003
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 11/2003
1	Cell Adhesion MoleculesIBA 11/2003
1	Myelin Basic ProteinIBA 08/2003
1	AntigensIBA 08/2003
1	Pharmaceutical PreparationsIBA 08/2003
1	Amino Acids FDA Link 08/2003
1	Intravenous Immunoglobulins (IVIG)FDA Link 04/2003
1	Macrophage Colony-Stimulating FactorIBA 04/2003
1	SelectinsIBA 03/2002
1	E-SelectinIBA 03/2002
1	P-SelectinIBA 03/2002

Therapy/Procedure

8	Therapeutics 05/2020 - 04/2003
2	Oral Diagnosis (Oral Examination) 01/2021 - 05/2019
2	Activities of Daily Living (ADL) 05/2020 - 09/2018
1	Carotid Endarterectomy 01/2021
1	Occupational Therapy (Therapy, Occupational) 09/2018
1	Speech Therapy (Therapy, Speech) 09/2018
1	Medical Day Care (Partial Hospitalization) 01/2017
1	Enteral Nutrition (Feeding, Tube) 01/2017
1	Gastrostomy 01/2017
1	Tracheotomy 01/2017
1	Secondary Prevention 02/2014
1	Intravenous Administration 03/2008
1	Duration of Therapy 08/2003
1	Immunomodulation 04/2003